Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Radiation Oncology (London, England)|September 29, 2021
Bench to bedside radiosensitizer development strategy for newly diagnosed glioblastomaCharlotte Degorre, Philip Tofilon, Kevin Camphausen, et al.Neuro-Oncology Practice|June 16, 2020
Radiosensitizers in the temozolomide era for newly diagnosed glioblastomaPeter Mathen, Lindsay Rowe, Megan Mackey, et al.Journal of Biochemistry and Analytical Studies|April 22, 2021
A Serum Proteomic Signature Predicting Survival in Patients with GlioblastomaMary Sproull, Peter Mathen, Charlotte Anne Miller, et al.Medical Physics|April 12, 2020
Automated glioma grading on conventional MRI images using deep convolutional neural networksYing Zhuge, Holly Ning, Peter Mathen, et al.Medrxiv : the Preprint Server for Health Sciences|July 17, 2026
Phase I dose escalation of the Exportin 1 inhibitor, Selinexor, in combination with chemoradiation in patients with newly diagnosed glioblastomaPeter Mathen, Huma Chaudhry, Megan Mackey, et al.Frontiers in Oncology|October 24, 2022
The prognostic impact of PD-L1 and CD8 expression in anal cancer patients treated with chemoradiotherapyAngela My Chan, Gloria Roldan Urgoiti, Will Jiang, et al.Practical Radiation Oncology|February 6, 2026
A phase 1 dose escalation trial of re-irradiation for patients with recurrent glioblastomaPeter Mathen, Andra V Krauze, Lindsay Rowe, et al.Journal of Neuro-Oncology|February 26, 2020
The prevalence of altered body image in patients with primary brain tumors: an understudied populationLindsay Rowe, Elizabeth Vera, Alvina Acquaye, et al.NPJ Precision Oncology|August 14, 2025
A review of diffuse hemispheric glioma, H3 G34-mutant disease development, DNA repair, microenvironment, and treatments on the horizonCameron Crowell, Ziwen Zhu, Yingxiang Li, et al.Pageof 1